Delta Lloyd NV increased its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 10.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 29,062 shares of the company’s stock after buying an additional 2,676 shares during the period. Delta Lloyd NV’s holdings in Thermo Fisher Scientific were worth $4,623,000 as of its most recent filing with the SEC.

Other large investors also recently added to or reduced their stakes in the company. Confluence Investment Management LLC increased its position in shares of Thermo Fisher Scientific by 2.1% in the third quarter. Confluence Investment Management LLC now owns 199,252 shares of the company’s stock valued at $31,693,000 after buying an additional 4,190 shares during the last quarter. PNC Financial Services Group Inc. increased its position in shares of Thermo Fisher Scientific by 15.2% in the third quarter. PNC Financial Services Group Inc. now owns 982,212 shares of the company’s stock valued at $156,230,000 after buying an additional 129,483 shares during the last quarter. Retirement Systems of Alabama increased its position in shares of Thermo Fisher Scientific by 34.1% in the third quarter. Retirement Systems of Alabama now owns 269,008 shares of the company’s stock valued at $42,788,000 after buying an additional 68,392 shares during the last quarter. Penserra Capital Management LLC increased its position in shares of Thermo Fisher Scientific by 100.0% in the third quarter. Penserra Capital Management LLC now owns 864 shares of the company’s stock valued at $137,000 after buying an additional 432 shares during the last quarter. Finally, Abner Herrman & Brock LLC increased its position in shares of Thermo Fisher Scientific by 6.9% in the third quarter. Abner Herrman & Brock LLC now owns 18,392 shares of the company’s stock valued at $2,925,000 after buying an additional 1,185 shares during the last quarter. Institutional investors own 86.28% of the company’s stock.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Thermo Fisher Scientific Inc. (NYSE:TMO) traded down 0.82% during trading on Wednesday, reaching $140.11. The company’s stock had a trading volume of 2,163,584 shares. The stock’s 50-day moving average is $149.29 and its 200 day moving average is $151.92. The company has a market cap of $55.35 billion, a P/E ratio of 28.01 and a beta of 1.24. Thermo Fisher Scientific Inc. has a 12 month low of $119.75 and a 12 month high of $160.68.

Thermo Fisher Scientific (NYSE:TMO) last posted its earnings results on Thursday, October 27th. The company reported $2.03 earnings per share for the quarter, topping analysts’ consensus estimates of $1.97 by $0.06. The firm had revenue of $4.49 billion for the quarter, compared to analysts’ expectations of $4.39 billion. Thermo Fisher Scientific had a net margin of 11.10% and a return on equity of 14.95%. The company’s revenue was up 8.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.80 earnings per share. On average, equities analysts forecast that Thermo Fisher Scientific Inc. will post $8.25 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, January 16th. Stockholders of record on Thursday, December 15th will be issued a dividend of $0.15 per share. The ex-dividend date is Tuesday, December 13th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.43%. Thermo Fisher Scientific’s dividend payout ratio (DPR) is presently 12.00%.

TRADEMARK VIOLATION NOTICE: This article was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this article on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark laws. The correct version of this article can be viewed at https://www.thecerbatgem.com/2016/11/30/delta-lloyd-nv-has-4623000-position-in-thermo-fisher-scientific-inc-tmo.html.

Several research firms have issued reports on TMO. Leerink Swann reaffirmed a “buy” rating and set a $175.00 price objective on shares of Thermo Fisher Scientific in a report on Sunday, November 20th. Cleveland Research downgraded Thermo Fisher Scientific from a “buy” rating to a “neutral” rating in a report on Friday, September 9th. Bank of America Corp. set a $180.00 price objective on Thermo Fisher Scientific and gave the stock a “buy” rating in a report on Friday, October 7th. Zacks Investment Research raised Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $172.00 price objective on the stock in a report on Thursday, October 13th. Finally, JPMorgan Chase & Co. began coverage on Thermo Fisher Scientific in a report on Thursday, September 22nd. They set an “overweight” rating and a $180.00 price objective on the stock. Two investment analysts have rated the stock with a hold rating and seventeen have given a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $164.37.

In other news, CEO Marc N. Casper sold 30,000 shares of Thermo Fisher Scientific stock in a transaction on Thursday, September 1st. The shares were sold at an average price of $151.17, for a total transaction of $4,535,100.00. Following the transaction, the chief executive officer now owns 308,647 shares in the company, valued at $46,658,166.99. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Marc N. Casper sold 28,797 shares of Thermo Fisher Scientific stock in a transaction on Friday, September 2nd. The stock was sold at an average price of $151.01, for a total transaction of $4,348,634.97. Following the transaction, the chief executive officer now owns 307,444 shares in the company, valued at approximately $46,427,118.44. The disclosure for this sale can be found here. Insiders own 0.52% of the company’s stock.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

5 Day Chart for NYSE:TMO

Receive News & Stock Ratings for Thermo Fisher Scientific Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc. and related stocks with our FREE daily email newsletter.